The European Life Settlement Association (ELSA) invites you to attend the Secondary Life Markets Conference | 2025 on Monday, September 15th, 2025, in Zurich, Switzerland.
The Secondary Life Markets Conference (SLMC) is ELSA’s flagship event and the only one in Europe covering the entire range of secondary life markets. SLMC brings together industry experts to discuss the latest topics and trends impacting the capital markets participation in global secondary consumer life markets.
SLMC 25 will be a one-day conference held both in-person and virtually, broadcast to our global audience, for those unable to come and join us in Zurich. Contact us to discuss attendance, speaking and sponsoring options for the Secondary Life Markets Conference | 2025.
SLMC is the largest event in Europe that covers the entire range of secondary consumer life markets. Attendees from across the capital markets, and longevity and mortality experts, connect to discuss the themes and topics impacting the industry.
SLMC features expert speakers from academia, business, capital markets, and public policy delivering in-depth presentations and panel discussions on the most pressing issues impacting capital market participation in the longevity and mortality markets.
SLMC’s sponsor roster is a ‘who’s who’ of companies and organisations active in the secondary consumer life markets. Sponsoring the SLMC showcases your brand as a leading contributor to the advancement of our industry.
Registration information coming soon for the LifeILS Conference | 2026
Bill Corry, CEO of asset manager Corry Capital, gets proceedings underway with a brief welcome address.
Longevity risk and mortality risk drive investment outcomes across a range of asset classes and investment strategies, but is 'life' itself an asset class? If not, why not? This panel digs into the nuances of the question in the opening session of the day.
In 2024, asset management firm, Conning, in partnership with ELSA, surveyed institutional investors and industry participants for the inaugural ELSA | Conning investor survey. In this presentaiton, Manu Mazumdar of Conning updates the audience with some top-level insights from the sophomore edition, which is due to publish in December 2025.
When most think of retirement planning, they think of annuities, or low-risk investments. Too rarely does life insurance - and therefore, life settlements - come up. This presentation explains why, and how life settlements should be viewed by the retirement advisor community.
Investors in the life settlement market rely on a diverse range of origination chanels when sourcing assets. This panel discusses the continued efforts to driver consumer demand for the life settlement option through innovation and market education.
The cohort of insureds in the life settlement industry began in the 1980s with those with severe health impairments, and has since changed dramatically to include individuals that are very healthy at the point of sale. This presentation discusses the demographic change and offers insights into any future trends.
Life expectancy reports are a foundational component of modelling longevity risk for a life settlement asset manager, but not all LE's are created equal. This panel discusses why deviations exist, and how asset managers interpret them for inclusion into their models.
The PHL Variable rehabilitation was a significant news story in the life settlement market, and, 18 months on, it is still waiting for a final decision. This presentation explains what is known currently, and speculates as to what the end game will look like for the industry.
Various interested parties in or adjacent to the life settlement market have come together at various points to file amicus briefs in court cases in the US. This presentation highlights a few which have led to wins - and losses - and offers insights into future filings could lead to positive outcomes.
As litigation activity continues to emerge in the life settlement industry, particularly with estate-driven lawsuits, investors and risk managers face increasing complexity in pricing this uncertainty. This presentation explores two actuarial frameworks for incorporating litigation risk into life settlement valuations.
Litigation activity is a constant companion to the life settlement market and takes various forms. This panel discusses the prevailing topics of the day that are, or should be, top of mind for life settlement asset managers and investors.